Latest News
Bayer completes acquisition of Perfuse Therapeutics to strengthen ophthalmology pipeline
17 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) confirmed on Wednesday that it has completed the acquisition of Perfuse Therapeutics Inc.Through this acquisition Bayer now holds full rights to PER-001, a...
Akeso reports Phase II data for ligufalimab in AML
...
Optimi Health introduces standardised microdose psilocybin capsules for clinical research
17 June 2026 - Optimi Health Corp (NASDAQ:OPTH) (CSE:OPTI) (FSE:8BN0), a commercial-stage GMP pharmaceutical manufacturer of regulated psychedelic drug products, announced on Tuesday that it has completed production of two microdose psilocybin finish...
Niowave and Ratio Therapeutics agree Actinium-225 supply deal for targeted alpha therapies
17 June 2026 - Medical radioisotopes manufacturer Niowave Inc and Ratio Therapeutics Inc, a clinical-stage pharmaceutical company developing radiopharmaceuticals for cancer treatment, announced on Tuesday a supply agreement for Actinium-225.Under thi...
Lilly acquires 4E Therapeutics to advance non-opioid chronic pain treatment
17 June 2026 - 4E Therapeutics Inc, a neuroscience company developing next-generation treatments for chronic pain, announced on Tuesday that it has been acquired by US pharmaceutical company Eli Lilly and Company (NYSE:LLY).This acquisition combines ...